William Comai, DO
Orthopaedic Surgery · Battle Creek, MINPI 1780683565
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.3% of the total across 20 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Stryker at 33.7% of the total. Reporting peaked in 2019 at $226 and has fallen 80.6% since, to $44 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in MI, where the typical reported total is $3,012.
Across 20 payments — averaging $21.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$142
- KCI USA, Inc.$70
- Pacira Therapeutics, Inc.$50
- Kaleo, Inc.$39
- Smith+Nephew$19
- Medtronic$16
- plus $86 from 7 others
What the payments were for
- Food & beverage$39794%
- Education$246%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 5 | $142 |
| KCI USA, Inc. | 1 | $70 |
| Pacira Therapeutics, Inc. | 2 | $50 |
| Kaleo, Inc. | 3 | $39 |
| Smith+Nephew | 1 | $19 |
| Medtronic | 1 | $16 |
| Alk-abello, Inc | 1 | $14 |
| Johnson & Johnson | 1 | $13 |
| Avanos Medical | 1 | $13 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
| AstraZeneca | 1 | $11 |
| Ferring Pharmaceuticals Inc. | 1 | $11 |
| Optinose US, Inc. | 1 | $11 |
How this compares
$421 in reported general payments places this provider in the 15th percentile of 829 orthopaedic surgery providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 165 | $1,683 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 98 | $858 |
| Pregabalin | 14 | $813 |
| Tramadol Hcl | 152 | $780 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 39 | $393 |
| Meloxicam | 60 | $220 |
| Gabapentin | 26 | $170 |
| Amoxicillin | 136 | $152 |
| Cephalexin | 11 | $87 |
| Clindamycin Hcl | 23 | $40 |
| Lorazepam | 15 | $14 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Battle Creek
- Joseph BurkhardtBattle Creek$479K
- Asheesh BediAnn Arbor$9.4M
- Jerome WiaterBeverly Hills$3.9M
- Mark PintoChelsea$3.2M
- Kyle AndersonBingham Farms$3.1M
- Stephen BartolDetroit$2.6M
- Jad KhalilSouthfield$1.9M
- Jeffrey FischgrundSouthfield$1.8M
- John BlahaAnn Arbor$1.5M
- David MarkelSouthfield$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.